RPP

Global Platelet Rich Plasma (PRP) Market Trends/Analysis Report 2023-2030: The 1.94 Billion Market is Poised for Strong Growth, Driven by Rising Demand in Cosmetic Surgeries and Sports Injuries - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 13, 2023
Health, Other Health, Maintenance, Sports medicine, Elective surgery, RPP, Orthopedic surgery, COVID-19, Acne, Research, USD, Plasma, Dermatology, Hospital, PRP, Patient, Pure, R, Human, Wound healing, Medical device

Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.

Key Points: 
  • Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.
  • Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions.
  • Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body's own natural tissue repair process to achieve improved form and function.
  • However, by January 2022, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.

Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use

Retrieved on: 
Monday, June 12, 2023
Research, Technology, Infectious Diseases, Other Technology, Other Health, Biotechnology, Pharmaceutical, Health, Science, Other Science, EUA, UDM, Hair, Infection, Bachelor, BMB, Allergy, Workflow, RPP, Culture, SARS-CoV-2, Software, Pneumocystis jirovecii, COVID-19, Eye, Aspergillus, Histoplasma capsulatum, CE marking, PCR, Nomenclature codes, Immunochemistry, Emergency Use Authorization, Federal Food, Drug, and Cosmetic Act, Panel, Coccidioides, RSV, RUO, Patient, Laboratory, Autoimmune disease, Molecular Probes, IVD, Growth, GPP, Immunodeficiency, Diagnosis, FDA, Mucor, Virus, Vaccine, Rhizopus, Applied Spectral Imaging, Rhizomucor, Fusarium, Cunninghamella, Cryptococcus

The Fungal Panel Assay was developed to detect the most common agents of invasive fungal infections (IFIs) particularly in lower respiratory samples.

Key Points: 
  • The Fungal Panel Assay was developed to detect the most common agents of invasive fungal infections (IFIs) particularly in lower respiratory samples.
  • Applied BioCode’s Fungal Panel is intended for research use only and may be used in infectious disease research or pharmaceutical development.
  • “Applied BioCode is thrilled to announce our first release of an RUO panel under our new product strategy.
  • Applied BioCode, Inc. has also been granted an Emergency Use Authorization (EUA) from the U.S. FDA for its BioCode® SARS-CoV-2 Flu Plus Assay ⱡ, BioCode® SARS-CoV-2 Assay*, and an additional EUA for Pooled COVID-19 Testing*.

Applied BioCode Announces Distribution Agreement with Medline Industries

Retrieved on: 
Monday, May 8, 2023
Infectious Diseases, Biotechnology, Hospitals, Health, EUA, Hair, Bachelor, BMB, Allergy, RPP, Medline Industries, SARS-CoV-2, COVID-19, Infection, CE marking, Applied Food Technologies, MEDLINE, Nomenclature codes, Lower respiratory tract infection, Immunochemistry, Emergency Use Authorization, Federal Food, Drug, and Cosmetic Act, Hospital, RSV, Analyte-specific reagent, Laboratory, Autoimmune disease, Molecular Probes, LDT, IVD, Diagnosis, GPP, FDA, Virus, Pharmaceutical industry, Vaccine

Applied BioCode today announced an agreement with Medline Industries, a leading manufacturer and distributor of healthcare products, to distribute the MDx-3000 System and its comprehensive menu.

Key Points: 
  • Applied BioCode today announced an agreement with Medline Industries, a leading manufacturer and distributor of healthcare products, to distribute the MDx-3000 System and its comprehensive menu.
  • Under the terms of the distribution agreement, Medline will offer the MDx-3000 System to clinical laboratory customers across the U.S.
    “Applied BioCode is thrilled to partner with Medline Industries, and we look forward to continuing our expansion into hospitals and reference laboratories in the U.S.,” said Chris Bernard, CEO of Applied BioCode.
  • For more information on the Applied BioCode’s platform and products, visit: https://apbiocode.com/products.htm
    Applied BioCode is an IVD manufacturer that designs, develops, and commercializes multiplex testing products.
  • Applied BioCode, Inc. has also been granted an Emergency Use Authorization (EUA) from the U.S. FDA for its BioCode® SARS-CoV-2 Flu Plus Assay ⱡ, BioCode® SARS-CoV-2 Assay*, and an additional EUA for Pooled COVID-19 Testing*.

Applied BioCode Announces 2022 Q4 and Full year Revenue

Retrieved on: 
Monday, February 27, 2023
FDA, Chemicals, Plastics, Manufacturing, Technology, Nanotechnology, Public Relations, Investor Relations, Other Travel, Communications, General Health, Travel, Other Manufacturing, Other Technology, Science, Other Science, Research, Health, Bacteria, CE marking, Emergency Use Authorization, Autoimmune disease, RPP, Overalls, Diagnosis, Fungus, IVD, RSV, Federal Food, Drug, and Cosmetic Act, Microbiology, Bachelor, Parasitism, Laboratory, Virus, Patient, Nomenclature codes, RUO, Growth, Immunochemistry, BMB, Yoy, Molecular Probes, Syndromic testing, Allergy, EUA, GPP, Hair, Infection, COVID-19, COVID, SARS-CoV-2, Video game, Vaccine

Applied BioCode announced today its 2022 revenue $13MM, which marks 13% growth year over year, hitting the company’s historic high.

Key Points: 
  • Applied BioCode announced today its 2022 revenue $13MM, which marks 13% growth year over year, hitting the company’s historic high.
  • Q4 revenue was just shy of $4MM representing 9% growth quarter over quarter.
  • Applied BioCode, Inc. has also been granted an Emergency Use Authorization (EUA) from the U.S. FDA for its BioCode® CoV-2 Flu Plus Assay ⱡ, BioCode® SARS-CoV-2 Assay*, and an additional EUA for Pooled COVID-19 Testing*.
  • Applied BioCode also partners with a variety of diagnostic companies with applications that include the infectious disease, autoimmune disease, allergy, gut microbiome, and veterinary markets.

RPP Containers Celebrates 25th Anniversary

Retrieved on: 
Tuesday, February 7, 2023
Philanthropy, Sustainability, Recycling, Consumer, Environment, Primary, Secondary, Education, Packaging, Chemicals, Plastics, Religion, Other Philanthropy, Manufacturing, Society, Meal, School, RPP, Student, Poverty, Jesuit Refugee Service, Tutoring

RPP Containers® , a leading custom manufacturer, stocking distributor, and recycler of reusable plastic bulk containers, is celebrating its 25th anniversary with a $250,000 donation for the education of over 1,000 students in Sub-Saharan Africa.

Key Points: 
  • RPP Containers® , a leading custom manufacturer, stocking distributor, and recycler of reusable plastic bulk containers, is celebrating its 25th anniversary with a $250,000 donation for the education of over 1,000 students in Sub-Saharan Africa.
  • Over the past few years, RPP has been working with the Society of Jesus-East Africa and the Jesuit Refugee Service-Eastern Africa to identify and pay the school fees for the neediest students in several different countries.
  • This year, its 25th anniversary year, RPP has committed to pay the school fees for over 1,000 students that attend primary and secondary schools, in 28 different schools, in 10 different African countries.
  • We know that God has blessed RPP tremendously over the years, and it is only fitting that we share these blessings with those less fortunate who could use our help.”

Renaissance Physicians Partners Launches Initiative to Acquire Independent Houston Providers

Retrieved on: 
Thursday, January 12, 2023
Health, Hospitals, Practice Management, Other Health, Managed Care, General Health, Medicine, Campaign for Better Health Care, Patient, Human, RPP, Physician, Health, Capital Group Companies, Health insurance, MD

Renaissance Physicians Partners (RPP), a physician-led organization, announced today that it plans to acquire independent physician practices and offer them a unique way to maintain their autonomy while providing financial stability and increasing provider satisfaction.

Key Points: 
  • Renaissance Physicians Partners (RPP), a physician-led organization, announced today that it plans to acquire independent physician practices and offer them a unique way to maintain their autonomy while providing financial stability and increasing provider satisfaction.
  • With the support of Capital Group for Better Health, RPP will acquire physician practices and provide administrative and operational support, and assist in optimizing workflows and systems based on provider experience.
  • “Our primary focus is to help physicians continue to provide excellent care for residents in the Houston area while operating a financially stable business,” said Kevin Horn, MD, chairman of RPP.
  • Practices owned by RPP will have the opportunity to participate in payer contracts through Renaissance Physicians Organization network, which has a collective network of 1,400 primary care physicians and specialists who are serving the needs of approximately 45,000 patients in Houston.

ACI Worldwide to Accelerate Indonesia’s Real-Time Revolution with New BI-FAST Payment Services and Expanded Bank Participation

Retrieved on: 
Thursday, December 8, 2022
Software, Payments, Data Management, Professional Services, Technology, Fintech, Digital Cash Management, Digital Assets, Security, Commerce, ACIW, ACI Worldwide, GDP, Ecosystem, Name, Pay, Bank, ASEAN, Risk management, RPP, Bank Indonesia, ACI, Risk, Mobile phone, Property management, Renting, Online shopping

Powered by ACI Worldwide, BI-FAST payment services will be extended to include bulk credit, direct debit and Request for Pay services.

Key Points: 
  • Powered by ACI Worldwide, BI-FAST payment services will be extended to include bulk credit, direct debit and Request for Pay services.
  • These participants and multi-tenant aggregators will all be using ACI Worldwides real-time payments solution to connect to BI-FAST.
  • ACI Worldwide is a global software company that provides mission-critical real-time payment solutions to corporations.
  • ACI, ACI Worldwide, ACI Payments, Inc., ACI Pay, Speedpay and all ACI product/solution names are trademarks or registered trademarks of ACI Worldwide, Inc., or one of its subsidiaries, in the United States, other countries or both.

NSTIC OTA Delivers Accelerated Hypersonic Weapons Testing

Retrieved on: 
Tuesday, December 6, 2022
Maintenance, OTA, Naval Surface Warfare Center, C2, NSTIC, Acceleration, SATCOM, U.S. Department of Defense Strategy for Operating in Cyberspace, United States Department of Defense, Partnership, Air force, NSWC, CPS, Dahlgren, ATI, TALON, BOA, Telemetry, Naval Surface Warfare Center Dahlgren Division, ANSER, Government, RPP, Navy, Multimedia, Manta, Army, UHF, Defence Analytical Services and Advice, NSWCDD, Motion, Roll-on/roll-off, Acquisition, 3D printing, Risk management, Q, Defense

The acceleration of hypersonic development and testing is increasing strain on the nation's major test ranges and the limited number of mobile instrumentation assets to support hypersonic weapons testing.

Key Points: 
  • The acceleration of hypersonic development and testing is increasing strain on the nation's major test ranges and the limited number of mobile instrumentation assets to support hypersonic weapons testing.
  • Whereas traditional acquisitions with FAR-based contracts can take years to contract, OTAs can often be executed within a few months.
  • A bridge in testing capability is now in place to support cost-effective hypersonic testing in the BOA with plans in motion to continue to develop assets to support the increasing demand signal for test and answer the Pentagon's call to support accelerated hypersonic weapon system testing.
  • NSTIC is sponsored by Naval Surface Warfare Center DahlgrenDivision (NSWCDD) and managed by Advanced Technology International (ATI).

Fraser Institute News Release: Government workers across Atlantic Canada receive 11.9% higher wages, on average, than comparable private-sector workers

Retrieved on: 
Tuesday, October 25, 2022
Government, Statistics, Review, National Association of Government Employees, Public sector, Education, RPP, Pension, Private sector, Labrador, Canada, Eye, Bangladesh Technical Education Board, Industry, Fraser Institute, GLOBE, Public policy, Private, Health insurance, Pension fund, Atlantic Canada

HALIFAX, Nova Scotia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Government workers enjoy a wage premium and more generous benefits compared to comparable private sector workers, finds a new study published by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.

Key Points: 
  • HALIFAX, Nova Scotia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Government workers enjoy a wage premium and more generous benefits compared to comparable private sector workers, finds a new study published by the Fraser Institute, an independent, non-partisan Canadian public policy think-tank.
  • The study, Comparing Government and Private Sector Compensation in Atlantic Canada, 2021 , finds that the wages of government employees in Atlantic Canada are 38.0 per cent higher, on average, than wages in the private sector in 2021, the most recent year of available comparable data from Statistics Canadas Labour Force Survey.
  • Government workers across Atlantic Canada enjoy more generous non-wage benefits, too.
  • Early retirement: Government workers in Atlantic Canada retired between 3.0 years (Nova Scotia) and 4.4 years (Newfoundland & Labrador) earlier on average than their private-sector counterparts.

Milliken and PureCycle advance circularity by launching new concentrate using recycled PP resin

Retrieved on: 
Friday, October 21, 2022
LinkedIn, U.S. Securities and Exchange Commission, Color, Milliken & Company, Procter & Gamble, SEC, Carbon footprint, GHG, Growth, PP, Science, P&G, Annual report, NASDAQ, Plastic, Olson, RPP, NX, Carbon, Procter and Gamble Baltimore Plant, Twitter, Recycling, Instagram, Partnership, Technology, UPR, Goal, Company, Industry, Chemistry, Public expenditure, Forward-looking statement, Gambling in Thailand, Solution, Risk, Fine chemical, Risk management, Marketing, Online gambling, Facebook

This development advances circularity, since the concentrate based on PureCycle materials will allow for greater use of 100% recycled content.

Key Points: 
  • This development advances circularity, since the concentrate based on PureCycle materials will allow for greater use of 100% recycled content.
  • Today's announcement of the first odorless concentrate for PP based on a recycled resin carrier was a direct result of that collaboration.
  • The game-changing technology separates color, odor and other contaminants from PP waste feedstock to transform it into ultra-pure, virgin-like resin.
  • Milliken's technical leadership and top-tier additives play a critical role in reinvigorating recycled polypropylene (rPP) for PureCycle.